- About
- PsychU For You
- Topics
- Events
- Content
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics
This is a Virtual Event for PsychU members in Delaware, Maryland, New Jersey, and Pennsylvania.
In this presentation, the objectives are to:
- Understand the impact of mood episode recurrence in Bipolar I Disorder on patient functioning and clinical outcomes
- Discuss risk factors for mood episode recurrence, including nonadherence, in patients with Bipolar I Disorder
- Review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in Bipolar I Disorder
Salvatore G. Savatta, MD
Chair of Psychiatry, Trinitas Regional Medical Center, Elizabeth, NJ
MoreDr. Salvatore G. Savatta received his Bachelor of Arts degree in Economics from New York University, graduated from New York University School of Medicine in 2001 and completed his M.S. in Biostatistics Clinical Research Methods at Columbia University’s Mailman School of Public Health in 2005. Dr. Savatta has previously served as Director of Inpatient Psychiatry at New York Methodist Hospital, Medical Director of TMS Centers of America and both Deputy Chair and Interim Chair of Psychiatry at Trinitas Regional Medical Center. He presently serves as Chair of Psychiatry at Trinitas and has done so since May of 2020. Dr. Savatta completed his Psychiatry Residency at St. Vincent’s Catholic Medical Center and completed a Public Service Psychiatry Fellowship and a Forensic Psychiatry Fellowship at the University of Pittsburgh Medical Center – Western Psychiatric Institute and Clinic. Dr. Savatta is Board Certified in both Adult Psychiatry and Forensic Psychiatry. He has tailored his clinical practice to focus on “difficult to treat” depression, and often includes the implementation of Neuromodulation techniques such as TMS, Esketamine, and Electroconvulsive Therapy (ECT) when clinically appropriate.
Mark Tacelosky, PharmD (OPDC)
Senior Medical Science Liaison
Speaker Salvatore G. Savatta, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Mark Tacelosky, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Related Events
Registration
- PsychU For You
